CLF and affected community residents will be back in Court on April 11th arguing that the high-level biocontainment laboratory proposed by Boston University (BU) has no place in the densely populated urban environmental justice community of Roxbury/ South End. Please join us in standing up for this important cause by attending the hearing in Boston on…
Many of you have been waiting for the next opportunity to voice your concern over the BU Biolab. Your time is coming – the state’s public comment process will begin soon, and the Patrick Administration needs to hear from you. The proponents of Boston University’s proposed National Emerging Infectious Diseases Laboratories (NEIDL) – known as…
Boston University (BU) and the National Institutes of Health (NIH) are preparing a mandatory revised risk assessment for BU’s National Emerging Infectious Disease Laboratories (NEIDL), which has received substantial federal funding through NIH. I described the specifics of this risk assessment in an earlier post. The draft of that risk assessment is currently ready for…
While much of Boston was distracted by the approaching holidays, public health and the environmental justice communities of Roxbury / South End scored a victory last Friday, December 23rd, when Secretary Sullivan issued his final decision to deny BU’s request to begin high level research at BU’s National Emerging Infectious Disease Laboratories (NEIDL) until a full risk assessment is reviewed by EOEEA.
There’s a common saying that if you can’t measure it, you can’t control it. Leaders of Boston University’s proposed National Emerging Infectious Diseases Laboratories (NEIDL) – known as the BU Biolab – in the densely populated urban Environmental Justice community of Roxbury/ South End, have asked the state to waive required review of their plans to build a lab involving rare and lethal pathogens even though their prior risk assessments were found inadequate multiple times. In other words, they want to build a risk laden facility without accountability to the public. We oppose the grant of this request.